Orbital Therapy debuts artifact-reducing insert for breast imaging

Breast cancer technology provider Orbital Therapy has announced the availability of its artifact-reducing insert for its ClearVue prone breast platform.

According to the Bedford, Mass.-based company, the patent-pending design of the new insert reduces the shadow effect projected through the breast to be treated, generated by the CT reconstruction process, resulting in a cleaner CT image of the breast.

 

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.